Profile data is unavailable for this security.
About the company
HLS Therapeutics Inc. is a pharmaceutical company. It is focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central nervous system and cardiovascular therapeutic areas. Its products include Clozaril, CSAN Pronto, MyCare Insite, MyCare Psychiatry, PERSERIS, Trinomia and Vascepa. Its lead product is Clozaril, which is an atypical antipsychotic indicated for the management of symptoms of treatment-resistant schizophrenia for the Canadian and United States markets. CSAN Pronto is a capillary point-of-care medical device designed to enhance and simplify the mandatory safety blood monitoring process for patients that are prescribed Clozaril. Trinomia product related to the treatment of cardiovascular disease.
- Revenue in CAD (TTM)86.17m
- Net income in CAD-37.61m
- Incorporated2018
- Employees91.00
- LocationHLS Therapeutics Inc10 Carlson Court, Suite 701ETOBICOKE M9W 6L2CanadaCAN
- Phone+1 (647) 495-9000
- Fax+1 (647) 495-9000
- Websitehttps://www.hlstherapeutics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pineapple Express Cannabis Co | 0.00 | 1.23m | 48.65m | -- | 39.61 | 33.58 | 39.50 | -- | 0.0442 | 0.0442 | 0.00 | 0.0521 | 0.00 | -- | -- | -- | 165.84 | -141.47 | 181.89 | -- | -- | -- | -- | -116.53 | -- | -- | 0.00 | -- | -30.45 | -- | 3.56 | -- | -- | -- |
Petmed Express Inc | 369.68m | -8.31m | 121.96m | 302.00 | -- | 0.7851 | -- | 0.3299 | -0.299 | -0.299 | 13.30 | 5.38 | 1.65 | 7.38 | 143.74 | 895,761.60 | -3.70 | 14.04 | -4.72 | 17.12 | 27.80 | 29.54 | -2.25 | 8.21 | 1.64 | -- | 0.00 | 100.72 | -6.06 | -1.27 | -98.90 | -63.26 | 49.56 | 7.14 |
CareRx Corp | 370.75m | -5.41m | 138.80m | 1.44k | -- | 1.70 | 9.53 | 0.3744 | -0.097 | -0.097 | 6.31 | 1.36 | 1.49 | 13.32 | 10.15 | -- | -2.18 | -13.05 | -2.92 | -19.36 | 28.24 | 28.91 | -1.46 | -9.70 | 0.7327 | 0.5676 | 0.5455 | -- | -2.88 | 25.54 | 84.27 | -- | 14.34 | -- |
Marimed Inc | 203.07m | -21.91m | 150.13m | 643.00 | -- | 1.52 | -- | 0.7393 | -0.043 | -0.043 | 0.409 | 0.2414 | 0.8532 | 3.69 | 26.17 | 231,101.10 | -9.19 | -13.42 | -10.88 | -17.50 | 44.36 | 49.18 | -10.77 | -14.83 | 0.8465 | 1.69 | 0.4395 | -- | 10.89 | 65.82 | -219.03 | -- | 18.39 | -- |
HLS Therapeutics Inc | 86.17m | -37.61m | 151.85m | 91.00 | -- | 1.14 | 25.22 | 1.76 | -1.17 | -1.17 | 2.67 | 4.17 | 0.2799 | 0.8271 | 6.80 | 957,463.30 | -12.22 | -7.09 | -14.02 | -8.09 | 87.91 | 92.49 | -43.65 | -33.62 | 1.30 | -2.26 | 0.4728 | -- | 2.61 | 0.5345 | -16.67 | -- | -24.71 | -- |
High Tide Inc | 497.66m | -35.87m | 239.21m | -- | -- | 1.72 | -- | 0.4807 | -0.4764 | -0.4764 | 6.57 | 1.75 | 1.99 | 14.41 | 69.05 | -- | -14.80 | -23.58 | -19.80 | -31.00 | 27.15 | 29.68 | -7.45 | -15.74 | 0.6894 | 0.6044 | 0.318 | -- | 36.66 | 123.48 | 45.22 | -- | 7.54 | -- |